Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

JTO clinical and research reports·2026
Same author

Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.

JAMA·2026
Same author

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026
Same author

Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026
Same author

Psychometric properties of the Chinese perceptions of inclusion questionnaire teacher version for pupils with intellectual and developmental disabilities in inclusive classrooms.

International journal of developmental disabilities·2026
Same author

Agar-modified gelatin/polyvinyl alcohol-based tough hydrogels for 3D printing to prepare multifunctional sensors and flexible supercapacitors.

Carbohydrate polymers·2026
Same journal

Gene-environment interaction analysis under the Cox model.

Annals of the Institute of Statistical Mathematics·2025
Same journal

Matrix completion under complex survey sampling.

Annals of the Institute of Statistical Mathematics·2023
Same journal

Generation of all randomizations using circuits.

Annals of the Institute of Statistical Mathematics·2023
Same journal

Nonparametric tests for multistate processes with clustered data.

Annals of the Institute of Statistical Mathematics·2022
Same journal

Semiparametric modelling of two-component mixtures with stochastic dominance.

Annals of the Institute of Statistical Mathematics·2022
Same journal

Weighted Estimating Equations for Additive Hazards Models with Missing Covariates.

Annals of the Institute of Statistical Mathematics·2019
See all related articles

Related Experiment Video

Updated: May 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Hazard Function Estimation with Cause-of-Death Data Missing at Random.

Qihua Wang1, Gregg E Dinse, Chunling Liu

  • 1Academy of Mathematics and Systems Science, Chinese Academy of Science Beijing 100080, China.

Annals of the Institute of Statistical Mathematics
|January 24, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces three novel nonparametric kernel estimators for hazard function estimation in survival analysis. These methods effectively handle randomly censored data with missing indicators, improving accuracy for cause-specific mortality.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: May 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Statistics
  • Biostatistics
  • Survival Analysis

Background:

  • Hazard function estimation is crucial in survival analysis, particularly for cause-specific mortality.
  • Existing methods may face challenges with randomly censored data and missing censoring indicators.

Purpose of the Study:

  • To propose three new nonparametric kernel estimators for hazard function estimation.
  • To address scenarios with random censorship and missing at random censoring indicators.
  • To provide statistically sound methods for cause-specific hazard estimation.

Main Methods:

  • Development of three nonparametric kernel estimators: regression surrogate, imputation, and inverse probability weighted.
  • Derivation of uniform strong consistency and asymptotic normality for all estimators.
  • Analysis of mean squared error and mean integrated squared error, including a data-driven bandwidth selection method.

Main Results:

  • The proposed estimators are uniformly strongly consistent and asymptotically normal.
  • Asymptotic properties of mean squared error and mean integrated squared error were derived.
  • A simulation study confirmed the good finite sample performance of the estimators.

Conclusions:

  • The three novel nonparametric kernel estimators offer robust solutions for hazard function estimation.
  • These methods are suitable for survival data with random censorship and missing indicators.
  • The study provides valuable tools for analyzing cause-specific mortality in complex datasets, as demonstrated with vascular disease data.